From Canada to China for Medical Care: Wait Times, Out-of-Pocket Costs, Insurance Pathways, and a Decision Framework

<strong

Reading time: 18 minutes

In late 2024, the Canadian Institute for Health Information (CIHI) reported the national median wait for hip replacement at 27 weeks — six and a half months from the surgeon’s listing date to operation. Knee replacement: similar [1]. The Wait Time Alliance benchmark of 26 weeks for joint replacement is met for fewer than half of Canadian patients across most provinces, and in 2024 roughly 6.5 million Canadians did not have a regular family doctor or nurse practitioner — about one in five adults [2].

Private insurance fills part of the gap. About two-thirds of Canadians hold some form of private health coverage through employer-sponsored plans (Sun Life, Manulife, Canada Life, Green Shield, GreatWest) — but these plans are weighted toward drugs, dental, vision, paramedical, not surgery. Hospital-level care in Canada is essentially synonymous with the public system; there is no parallel private surgical pathway comparable to UK Spire or Australian Ramsay.

This is why Canadian residents are starting to look outward. This article helps you decide: does your situation actually warrant looking at China? If it does, what’s the pathway, what does it cost, will your insurance work, and what’s the process from end to end?

1. Where the Canadian public system actually bottlenecks

Canadian Medicare’s foundational principle — universality, allocation by medical need not ability to pay — remains sound. But when demand outstrips supply, the allocation mechanism is queuing. CIHI 2024 data shows the real cadence [1]:

Procedure	National median wait	Share meeting WTA benchmark
Hip replacement	27 weeks	~58%
Knee replacement	28 weeks	~55%
Cataract surgery	14 weeks	~70%
CT (non-urgent)	4–10 weeks	—
MRI (non-urgent)	12–18 weeks	—
Specialist consult (orthopaedic)	11–30 weeks (varies by province)	—
Specialist consult (oncology, urgent)	2–6 weeks	—
Bariatric surgery	1–3 years (some provinces)	—
Endoscopy (colonoscopy)	3–8 months	—

What provincial Medicare actually covers (and doesn’t) [3][4]:

Covered: family doctor visits, specialist consults (with referral), hospital admissions and surgery, A&E, diagnostic imaging by referral, in-hospital medications.
Not covered or partly covered: outpatient prescription drugs (varies by province — Ontario OHIP+, Quebec RAMQ, B.C. PharmaCare have varying age and income rules), dental beyond emergency, vision beyond children/seniors, most outpatient mental health, almost all planned out-of-province (let alone out-of-country) elective care.
The hard rule: you cannot pay out-of-pocket to jump the queue inside a Canadian public hospital. The Canada Health Act blocks parallel private inpatient surgery in most provinces.

What Canadian “private” care actually looks like:

Employer drug/dental/vision plans (Sun Life, Manulife, Canada Life, Green Shield) cover medications, dental, vision, paramedical — not surgery.
A small number of private MRI / CT / ultrasound clinics exist in Quebec, B.C., Alberta and Saskatchewan, providing diagnostic imaging at CAD $700–$2,500 self-pay.
The Cambie Surgeries case in B.C. confirmed the legal limits — most provinces don’t allow private surgical clinics to provide medically necessary care covered by Medicare.
This is why Canadians needing speed have historically flown to the US (Mayo, Cleveland Clinic, MD Anderson), increasingly to Mexico for dental and bariatric, and now increasingly to Asia (China, Thailand, India) for joint, oncology, advanced therapy, and executive physicals.

2. Situations where “look at China” is a reasonable decision

Not every medical need suits cross-border care. Below are the situations where, in our experience, Canadian residents have a real case for considering China.

Situations that suit a China pathway

🟢 Wait-time-sensitive

Hip and knee replacement, spine decompression, cataract — Canadian public waits of 27+ weeks, no real private fast-track inside Canada, procedures are mature, and you can fly home shortly after.
IVF evaluation — provincial coverage varies wildly (Ontario one funded cycle, Quebec multiple, others none); private cycle CAD $10,000–$15,000.
Bariatric surgery — provincial waits of 1–3 years in some regions; China sleeve gastrectomy at private international is reachable in 2–3 weeks.

🟢 Diagnostic-acceleration cases

PET-CT for cancer staging or recurrence monitoring — China 3–7 days, Canadian public 4–12 weeks, Canadian private self-pay CAD $2,500–$4,000.
High-field MRI, endoscopy — 3–5 day packages in China.
Pathology slide re-reading — remote, no travel needed.

🟢 Second opinion and plan confirmation

You have a Canadian diagnosis and treatment plan and want to pressure-test it.
Oncology, haematology, complex surgical decisions warranting MDT review.
Canadian specialists generally welcome second opinions; an international second opinion (including from China) is defensible.

🟢 Advanced therapies that already point to China

CAR-T cell therapy — six NMPA-approved products in China at roughly 1/4 to 1/3 of US self-pay (where Canadians historically went). Canadian provincial coverage of CAR-T is narrow.
Proton and heavy-ion therapy — Canada has two operating proton centres (TRIUMF Vancouver, limited indications; The Princess Margaret partnership models). No operating heavy-ion centre. China’s Shanghai Proton and Heavy Ion Center (SPHIC, public) and the Heyou Proton & Heavy Ion Center inside Heyou Pinnacle Medical Center (private, Foshan-Shunde) are among the very few centres on the Chinese mainland equipped with both proton and heavy-ion capability [13].
Certain biologics — broader access, lower pricing.

🟢 Premium executive physicals and early-cancer screening

Comprehensive packages completed in 3–5 days.
Imaging quality on par with top Canadian academic centres.
English-speaking International Medical Departments — no language barrier for Canadian residents.

Situations that don’t suit China

🔴 Emergencies and critical illness — heart attack, stroke, major trauma, uncontrolled infection, severe bleeding. Handle locally. Crossing borders is itself the medical risk.

🔴 Unstable patients who can’t fly long-haul — fit-to-fly must be assessed by your existing treating physician, not by us.

🔴 Expecting “a miracle cure” — if Canadian oncology has called your case untreatable, “China must have something” is usually disappointment in waiting.

🔴 Price as the sole driver — Mexico, Thailand or India may be cheaper for some procedures. China’s edge is the combination of clinical depth, price, and speed. Lowest price is not the headline.

3. Two systems in China — and a bridge that runs only one way

This is the part Canadian patients most often misunderstand. We need to be explicit, because misunderstanding it costs you money.

Chinese hospitals fall into two distinct systems:

Public Tier-3A hospitals

Tier-3A (三级甲等) is the top rank in China’s hospital classification — equivalent to a Canadian academic teaching hospital (Toronto General, Vancouver General, Montreal MUHC, Foothills Calgary).
Examples: Peking Union Medical College Hospital (Beijing), Beijing Tiantan Hospital, Shanghai Ruijin Hospital, Fudan-Zhongshan, Sun Yat-sen Memorial in Guangzhou, and many others.
Strengths: concentration of senior specialists, very high surgical volumes, can handle the most complex cases, costs are 30–50% of private international.
Weaknesses: limited English in general wards (you’ll need interpretation and accompaniment), queue logic built around domestic patient flow, inpatient wards utilitarian rather than hotel-grade.
The International Medical Department (IMD) is the dedicated bilingual channel inside top Tier-3A hospitals — PUMCH, West China, Ruijin, Huashan, Zhongshan and others all run IMDs designed for international patients.

Private international hospitals — more complex than you’d think from abroad

Examples: United Family Healthcare (Beijing/Shanghai/Guangzhou), Shanghai Jiahui International Hospital, Heyou Pinnacle Medical Center (Foshan-Shunde, founded by the founder of Midea Group with combined system investment of over RMB 10 billion), Concord Medical’s Guangzhou Concord Cancer Center (proton therapy operational from late 2024), and others.
Strengths go beyond service: fluent English, comprehensive insurance direct billing, hotel-style rooms, on-time appointments, transparent international workflow. But a small number of leading private hospitals also run equipment that matches or surpasses most public hospitals — Heyou Pinnacle’s affiliated Heyou Proton & Heavy Ion Center is led by Professor Lu Jiade, who established the clinical technology system at Shanghai SPHIC [13], making it one of the few proton-and-heavy-ion-capable centres on the Chinese mainland. Guangzhou Concord Cancer Center became South China’s first operating private proton therapy centre in late 2024.
Physician composition isn’t simple either: the overwhelming majority of China’s top specialists remain in the public Tier-3A system, but in recent years a smaller cohort of senior physicians have moved part-time or full-time into private hospitals, drawn by compensation, research autonomy, and lower administrative load. Heyou Pinnacle is the clearest case in point — beyond Lu Jiade, the group has attracted Li Baomin (national pioneer in neurointervention, 20,000+ stent placement and embolisation cases), Su Fengxi (Honorary President of Sun Yat-sen Memorial Hospital’s Breast Tumor Hospital, over 10,000 breast cancer surgeries, national leader in breast-conserving surgery), and other senior specialists. The blanket assumption “private equals weaker doctors” is too simple. What matters is who the lead surgeon is, what their actual surgical volume in that procedure is over the last 12 months, and the team behind them.
The real complexity: Chinese private hospitals are a hybrid system where the bulk of authority still sits in public Tier-3A, but local capability is iterating quickly in pockets. Which private hospital can perform which procedure at what level, who can take over post-op care, whether your insurance is in-network — these are case-by-case, hospital-by-hospital, surgeon-by-surgeon decisions. That’s the work MedCareInChina actually does.
Shared weakness: the most complex, specialty-defining procedures (top-tier oncology, complex cardiac, complex neuro, transplant) — public Tier-3A remains the primary route. Private coverage is expanding rapidly but unevenly.

⚠️ The one-way bridge — the rule you can’t afford to get wrong

Canadian patients often assume they can “do diagnostics at private and surgery at public.” That path does not work in China.

The actual rule is asymmetric:

✅ Public → Private works. A diagnosis, imaging report, or prescription issued by a public Tier-3A hospital is recognised by private international hospitals. Private hospitals will continue prescribing, do follow-up, and conduct monitoring on the basis of the public hospital’s work.
❌ Private → Public does not. A private hospital’s consultation, imaging interpretation, or treatment plan is generally not accepted by a public Tier-3A as the basis for surgery or admission. If you want public treatment, the public hospital will require its own physicians to evaluate from scratch — frequently including repeat imaging and pathology review.

The reason: public Tier-3A is the higher-ranked tier in the Chinese medical hierarchy, and the downstream (private) accepts the upstream (public), but not vice versa.

What this means for your decision:

Complex cases (specialty-defining: top oncology, complex cardiac, complex neuro, transplant): stay in the public Tier-3A system end-to-end — from initial evaluation through surgery through follow-up. Same team, same chart, most accurate post-op judgment.
Routine cases (outpatient, imaging, executive physical, IVF, general specialty, dermatology, ophthalmology): stay in private international end-to-end. No reason to involve public.
The Public → Private follow-up bridge: appropriate for stable patients who’ve completed public treatment and need routine medication management or monitoring, especially those for whom English and service experience matter. Not appropriate for complex post-operative tracking.
❌ What not to do: assume you can run diagnostics at private and “save money by getting the surgery at public.” The result is paying for the workup twice.

4. Real cost comparison (CAD/USD, all at 1 USD = 6.5 RMB)

The table below combines CIHI public data, Canadian private clinic price lists, and published price ranges from Chinese public and private international hospitals. All figures are ranges, not commitments. The final invoice depends on actual treatment, length of stay, complications, and insurance review.

Procedure	Canada Public (Medicare)	Canada Private / US Self-Pay	China Public IMD + Accompaniment	China Private International
Hip replacement	Wait 27 weeks, covered	CAD $25,000–$35,000 (US private)	USD $8,000–$12,000	USD $15,000–$22,000
Knee replacement	Wait 28 weeks	CAD $25,000–$35,000 (US private)	USD $8,000–$12,000	USD $15,000–$22,000
Spine fusion (single level)	Wait 6+ months	CAD $50,000–$80,000 (US private)	USD $12,000–$18,000	USD $25,000–$35,000
Cataract (standard IOL, one eye)	Wait 14 weeks	CAD $3,500–$5,000 (Quebec private)	USD $800–$1,500	USD $2,500–$4,000
Cataract (premium multifocal IOL)	Not covered	CAD $5,500–$8,500	USD $2,000–$3,500	USD $4,500–$7,000
PET-CT	Partly covered (specific cancers)	CAD $2,500–$4,000 (private)	USD $1,500–$2,500	USD $2,500–$3,500
MRI	Wait 12–18 weeks	CAD $700–$1,500 (private clinic)	USD $200–$500	USD $500–$900
Comprehensive checkup (incl. PET-CT)	Not covered	CAD $4,000–$10,000	USD $2,500–$4,500	USD $5,500–$9,500
Upper + lower endoscopy (with anaesthesia)	Wait 3–8 months	CAD $2,500–$4,500 (private)	USD $700–$1,500	USD $2,000–$3,500
IVF, single cycle	Coverage varies by province	CAD $10,000–$15,000	USD $5,000–$8,000	USD $10,000–$16,000
Bariatric (sleeve gastrectomy)	Wait 1–3 years (some provinces)	CAD $15,000–$22,000 (Mexico/US)	USD $8,000–$12,000	USD $15,000–$22,000
CAR-T cell therapy	Provincial coverage narrow	USD $400K+ (US list)	USD $160K–$220K (all-inclusive)	Not performed at private
Proton / heavy-ion therapy	TRIUMF Vancouver narrow indications	US private USD $80K–$200K	USD $30K–$50K (SPHIC, public; proton + heavy-ion)	Heyou Pinnacle (proton + heavy-ion); Guangzhou Concord (proton); case-by-case

Notes on what the table doesn’t show:

The “Canadian private” column above mostly reflects US destination pricing — because there is no real Canadian private surgical equivalent. Canadians needing speed historically fly to US Mayo/Cleveland/MD Anderson at full self-pay.
Canadian Medicare’s “free” coverage has a cost denominated in time. A patient waiting 28 weeks for a knee replacement and living on painkillers for seven months pays a real cost that isn’t money.
The bigger structural gap is speed. China private international: 1–2 weeks from arrival to surgery. US private: 2–6 weeks. Canadian public: 27+ weeks for joint replacement.

5. Do Canadian insurance plans actually work in China?

The honest answer: it depends on which plan you hold and whether your insurer has a direct-billing contract with your target hospital.

International medical insurance networks in China (2025 status)

The following are available to Canadian residents and have substantial direct-billing networks in China [14]:

Bupa Global [6] — Expanded in 2025 to 3,600 designated hospitals across 300 cities, covering both public IMDs and private internationals. Canadian Bupa Global policies are available through specialty brokers.
Cigna Global [5] — global network of 1.65M facilities; Shanghai operations centre; China direct billing covers both public and private. Available to Canadian residents through Cigna’s international channel.
AXA Global Healthcare [9] — AXA’s international product. Via Prosper Health partnership, covers approximately 1,350 Tier-3A public hospitals (including PUMCH, Sun Yat-sen, Huashan) plus major private internationals.
Allianz Worldwide Care [7] — 280+ public IMD and private international hospitals in China.
MSH International [8] — 500+ hospitals across 20+ cities, covering both public and private.
GeoBlue / IMG — North American international products, available to Canadian residents through brokers.

Plans that generally won’t work for planned care in China (Canadian domestic)

Provincial Medicare (OHIP, MSP, AHCIP, RAMQ, etc.) — covers no planned care outside Canada beyond very narrow Out-of-Country Prior Approval programs (used almost exclusively for treatments unavailable in Canada).
Sun Life, Manulife, Canada Life, Green Shield, GreatWest employer plans — drugs, dental, vision, paramedical only. No surgical coverage abroad.
Travel insurance — covers sudden illness and accidents only, not planned treatment.
Snowbird supplemental — same — emergencies only.

Direct billing vs reimbursement

Direct billing: the insurer pays the hospital directly; you cover only your deductible and copay. The widely repeated claim that “only private international hospitals support direct billing” is out of date — leading public Tier-3A IMDs now run extensive direct-billing networks. Concrete examples [14]:

Public IMD	Direct-billing insurers
Shanghai Huashan IMC	30+ direct billing contracts, ~100 actual partnerships; insurance business accounts for over 50% of revenue
Shanghai Ruijin IMD	20+ direct-billing insurers (system in place since 1998)
Peking Union (PUMCH) IMS	Maintains a full “Cooperative Commercial Insurance Roster” including major international insurers
Sun Yat-sen 1st Affiliated Hospital Nansha IMC	15 commercial insurers (opened 2023)

Private international hospital	Direct-billing insurers
Shanghai Jiahui International Hospital	~60 global insurers (broadest in East China)
Shanghai ParkwayHealth / SIMC	50+ direct billing; SIMC 60+ global partners
United Family Healthcare (Beijing/Shanghai/Guangzhou/Shenzhen/Boao)	22 international insurers
Heyou Pinnacle Medical Center (Foshan-Shunde)	Supports international commercial insurance direct billing; designated institution under the GBA “HK/Macao Drug & Device Access” policy

The decision criterion isn’t public vs private — it’s whether your specific insurer has an active direct-billing contract with the specific hospital you’re targeting. That has to be confirmed in writing before you travel.

Reimbursement (when direct billing isn’t available): you pay out of pocket, then claim back home. Almost all international policies accept this, but you’ll need:

English-language medical records, itemised bills, and the Chinese tax invoice (Fapiao).
Pre-authorisation filed with your insurer in advance (typically 24–48 hours processing).
Treatment falling within your policy scope.
A 4–12 week processing window.

What we can do, and what we don’t

⚠️ MedCareInChina is not an insurance company. We do not negotiate with your insurer on your behalf, and we do not advance insurance funds.

What we can do:

Help you confirm with your insurer whether your policy covers your planned treatment and whether your target hospital is in-network.
Help you prepare the pre-authorisation package your insurer requires (treatment plan, cost estimate, specialist letter).
Coordinate direct-billing communication and GOP (Guarantee of Payment) application between the Chinese hospital and your insurer.
After discharge, organise your English-language medical records, bills, and payment receipts for your reimbursement claim back home.

What we don’t do:

Make insurance decisions for you.
Promise your insurer will approve.
Hold or pass through insurance funds (all medical fees go directly from you to the hospital).

6. The five steps of going from Canada to China for care

Total elapsed time from your first email to your return flight is roughly 6–12 weeks (not counting treatment itself).

Step 1 · Free Pathway Scan (1–2 business days)

Send us a short email. Tell us:

Your current condition or diagnostic direction
Your Canadian province/city and a rough travel window
Whether you carry international medical insurance
A description of records you have on hand

We reply within 1–2 business days with whether your situation is worth continuing, a recommended next step, and additional records to gather.

This step is free, with no commitment. If we judge your situation isn’t right for China, we’ll tell you directly.

Step 2 · Remote Expert / MDT Consultation (5–10 business days, paid)

Single Expert: USD $800 flat — includes records organisation, Chinese case brief, specialist matching, video consultation, and a bilingual PDF report.
MDT (Multidisciplinary Team): USD $1,000 per specialist (typical MDT = 3 specialists = USD $3,000) — suited for complex oncology, cross-specialty decisions.
Your records get translated and organised into a Chinese-language case brief.
We match a suitable Chinese specialist (public Tier-3A or private international, based on your case).
A bilingual English-Chinese consultation report is delivered within 5–10 business days.

You can take this report back to your Canadian family doctor or specialist for discussion. You can also stop here — our service can end at this step.

Step 3 · S2 Medical Visa (2–4 weeks)

S2 visa [15][19]: medical treatment ≤6 months. Requires a Chinese-hospital-issued invitation letter.
S1 visa: medical treatment >6 months, allows accompanying family.
L visa (tourist): not recommended for sustained treatment.

⚠️ MedCareInChina does not process visas. Coordinate the invitation letter, yes; submit the visa, no. Canadian residents apply through the Chinese Embassy in Ottawa or consulates in Toronto, Vancouver, Calgary, Montreal, via the CVASC (Chinese Visa Application Service Centre) [20].

Invitation letter: 5–10 business days. Standard CVASC visa processing: 4–7 business days. Expedited service available.

Step 4 · In-China Accompanied Care (during treatment)

Airport pickup, appointment coordination, medical interpretation, payment coordination, insurance documentation support, English-language discharge files, hand-off to your Canadian clinician.

Typical durations: hip/knee replacement 5–7 days inpatient + 1–2 weeks observation = 2–3 weeks; cataract 3–4 days; checkup 3–5 days.

Fee structure:

Consultation fee (Step 2): paid to MedCareInChina.
Accompanied care service fee: stated in writing before you sign.
Hospital and physician fees: paid directly to the hospital. MedCareInChina does not handle medical funds.
Hotel, flights, transport: you arrange and pay directly. We don’t book these.

Step 5 · Remote follow-up after returning home

Back in Canada: Chinese attending physician schedules remote follow-up at agreed time points. We continue coordinating communication between the Chinese hospital and your Canadian clinician. For any emergency, seek local Canadian emergency care immediately.

7. When you shouldn’t consider China

You’re currently admitted in a Canadian hospital and unstable.
You don’t yet have baseline diagnosis, imaging, or medication records.
You’re hoping “China must have something” for late-stage disease Canadian oncology has called untreatable.
Cost is your only driver — Mexico, Thailand, India may be more cost-optimal.
You can’t accommodate a 6–12 week process.
Your insurance excludes overseas care and self-pay is genuinely outside your budget.

8. Frequently asked, honestly answered

Q: Can my Canadian family doctor or specialist be involved from the start?
Yes — we encourage it. Consultation reports are bilingual specifically so you can hand them to your Canadian clinician.

Q: Can the consultation report be used to support Bupa Global / Cigna / AXA reimbursement?
Depends on your policy. Provincial Medicare and Canadian employer plans generally don’t reimburse planned overseas care. International insurers (Bupa Global, Cigna Global, AXA Global Healthcare) vary — confirm with the insurer directly.

Q: If something goes wrong during surgery, who’s responsible?
The Chinese hospital. MedCareInChina is not a medical provider, does not make medical decisions, and is not responsible for medical outcomes. See our Terms of Service and Medical Disclaimer [22].

Q: Can I request a specific hospital or physician?
You can express a preference; we don’t guarantee we can match it. Final matching depends on physician schedule, willingness to take international patients, and case-specialty fit.

Q: Do I need a family member with me?
Outpatient and minor procedures: solo is fine. Major surgery and inpatient: strongly recommended with a family member (S2 visa supports accompanying family). Otherwise our accompanied-care service covers most needs.

Q: How soon after surgery can I fly back to Canada?
Cataract: day 2. Joint replacement: 2–3 weeks observation. Spine: 3–4 weeks. Major cancer surgery: 4–6 weeks. Fit-to-fly is issued by the treating physician, not by us.

Q: What if the treatment turns out not to fit on arrival?
This is exactly why we insist on remote consultation before travel. The Chinese hospital and you make any plan-change jointly. We don’t make medical decisions for you.

Q: Should I choose public or private in China?
Complex specialty-defining cases (oncology, complex cardiac, neuro, transplant) — public Tier-3A is essentially the only option. Routine outpatient/imaging/checkup/general specialty — private international handles the whole thing. The middle ground is genuine case-by-case work — that’s what we do.

9. Next step — send us your case

📧 hello@medcareinchina.com

Subject: Pathway Scan from Canada

In the body, tell us:

Your current condition or diagnostic direction (one or two sentences)
Your Canadian province/city and rough travel window
Whether you carry international medical insurance (insurer name is enough — no policy number needed)
The state of your medical records — describe; don’t send files yet

We respond within 1–2 Canadian business days with a free written assessment.

This step is always free. No payment, no commitment, no follow-up marketing emails.

Sources

[1] CIHI · Wait Times for Priority Procedures in Canada 2024 — Canadian Institute for Health Information national wait time data. https://www.cihi.ca/en/wait-times-for-priority-procedures-in-canada

[2] Statistics Canada · Primary Health Care Providers 2024 — Canadians without a regular health care provider. https://www.statcan.gc.ca/en/subjects-start/health

[3] Health Canada · Canada Health Act Overview — Federal framework for provincial health insurance. https://www.canada.ca/en/health-canada/services/canada-health-care-system.html

[4] Provincial Ministries of Health — OHIP (Ontario), MSP (B.C.), AHCIP (Alberta), RAMQ (Quebec) — covered service definitions.

[5] Cigna Global · International Health Insurance — China direct billing network. https://www.cignaglobal.com/

[6] Bupa Global · Find a Provider — Bupa Global network and direct-billing arrangements in China (2025 expansion to 3,600 designated hospitals across 300 cities). https://www.bupaglobal.com/en/customers/find-a-provider

[7] Allianz Care · International Medical Insurance — China provider network (280+ public IMD and private international hospitals). https://www.allianzcare.com/

[8] MSH International — China direct billing network (500+ hospitals across 20+ cities). https://www.msh-intl.com/

[9] AXA Global Healthcare — AXA’s international product. Via Prosper Health partnership covers approximately 1,350 Tier-3A hospitals. https://www.axaglobalhealthcare.com/

[10] GeoBlue / IMG — North American international medical insurance options for Canadian residents.

[11] Canadian Institute for Health Information · Health Expenditure Trends — Canadian health expenditure baseline. https://www.cihi.ca/en/national-health-expenditure-trends

[12] MedCareInChina · CAR-T Cell Therapy in China — China CAR-T pricing comparison. https://medcareinchina.com/car-t-cell-therapy-in-china-six-approved-products-top-centers-pricing-and-comparison-with-western-centers/

[13] Shanghai Proton and Heavy Ion Center (SPHIC) + Heyou Pinnacle Medical Center (Foshan-Shunde) + Guangzhou Concord Cancer Center — Reference for proton and heavy-ion therapy options in China. Heyou Pinnacle’s Heyou Proton & Heavy Ion Center is directed by Professor Lu Jiade, who established the clinical technology system at SPHIC; Guangzhou Concord Cancer Center (Concord Medical Group) launched proton therapy operations in December 2024. https://medcareinchina.com/proton-and-heavy-ion-therapy-in-china-sphic-process-indications-and-comparison-with-us-japan-and-europe/

[14] MedCareInChina · International Medical Insurance and China Hospital Direct Billing — Public IMD direct-billing roster (Huashan ~100 partnerships, Ruijin 20+, PUMCH cooperative insurance roster, Sun Yat-sen Nansha 15) and private hospital networks (Jiahui ~60, ParkwayHealth 50+, United Family 22, Heyou Pinnacle GBA designation). https://medcareinchina.com/international-medical-insurance-and-china-hospital-direct-billing-a-complete-guide-to-coverage-workflow-and-pitfalls/

[15] MedCareInChina · Complete Guide to China Medical Visa (S1/S2). https://medcareinchina.com/complete-guide-to-china-medical-visa-s1-s2-the-first-step-for-international-patients/

[16] Mayo Clinic International Patient Services — US destination reference. https://www.mayoclinic.org/patient-visitor-guide/international-services

[17] Cleveland Clinic Global Patient Services — US destination reference. https://my.clevelandclinic.org/about/global-patient-services

[18] MD Anderson International Center — US destination reference. https://www.mdanderson.org/patients-family/becoming-our-patient/international.html

[19] Embassy of the People’s Republic of China in Canada · Visa Information — Official S1 and S2 medical visa rules for Canadian applicants. http://ca.china-embassy.gov.cn/eng/

[20] Chinese Visa Application Service Centre (CVASC) · Canada — Visa processing centres serving Canadian residents (Ottawa, Toronto, Vancouver, Calgary, Montreal). https://www.visaforchina.cn/

[21] Canadian Life and Health Insurance Association (CLHIA) — Canadian private insurance industry data. https://www.clhia.ca/

[22] MedCareInChina · Service & Refund Policy / Medical Disclaimer / Privacy Policy. Service & Refund Policy · Medical Disclaimer · Privacy Policy

Last updated 2026-05-29. All USD/CAD/RMB conversions calculated at 1 USD = 6.5 RMB; actual exchange rate at settlement applies. All medical decisions remain between you and your treating physician. MedCareInChina provides patient navigation services; it is not a medical provider, does not diagnose, does not prescribe, and does not guarantee treatment outcomes.

— MedCareInChina Editorial Team